This study is in line with several other studies reporting increased levels of TGF-β1 in patients with IBD [43,44] while others report increased levels in patients with successful anti-TNF treatment, suggesting an active suppression of the inflammatory response and tissue repair [45]. The gene discussed is TGFB1; the disease is inflammatory bowel disease.